COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older (any sex) who have a confirmed diagnosis of COPD based on 2024 GOLD guidelines, which includes a history of exposure to risk factors (such as smoking) and breathing test results showing airflow limitation, along with a symptom score of 10 or higher on a standard COPD questionnaire
- People whose COPD is classified as GOLD Group E, meaning they have had 2 or more moderate flare-ups, or at least 1 severe flare-up requiring a hospital stay, in the past year
- People with severe or very severe COPD (GOLD stage 3 or 4), where breathing tests show lung function has dropped below 50% of what is expected
Who may not be able to join:
- People who have advanced scarring lung disease affecting 50% or more of the lungs
- People who have high-risk pulmonary hypertension (high blood pressure in the lungs) and are currently on a three-medication treatment plan for it
- People who have active cancer and are currently receiving systemic treatment (such as chemotherapy or similar therapies that work throughout the whole body)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-877-240-9479
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of hospitalizations; Incidence of exacerbations; Incidence of Mortality
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.